NASDAQ:SRTS Sensus Healthcare Q3 2026 Earnings Date & Estimates $2.89 -0.04 (-1.37%) Closing price 04:00 PM EasternExtended Trading$2.90 +0.01 (+0.35%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Sensus Healthcare is estimated to report Q3 2026 earnings on Thursday, November 5, 2026, before market opens. The conference call is scheduled for 4:30 PM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ3 2026Announcement DateNovember 5, 2026TimeBefore Market OpensConference Call4:30 PM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from Sensus Healthcare in Q3 2026Sensus Healthcare is expected to post earnings of -$0.0550 per share on revenue of $6.61 million. In the same quarter a year earlier Sensus Healthcare reported -$0.06 per share on revenue of $6.88 million. Sensus Healthcare last reported on August 13, 2026, posting -$0.53 per share and missing the -$0.1250 consensus estimate. Sensus Healthcare has beaten the consensus EPS estimate in 2 of its last 8 quarters.Consensus EstimatesConsensus EPS-$0.0550Expected Revenue$6.61 millionPrior-Year EPS-$0.06Prior-Year Revenue$6.88 millionExpected Revenue Growth-3.9%Recent Track RecordLast ReportedQ2 2026Last Quarter EPS-$0.53 (Missed by -$0.4050)Last Quarter Revenue$2.29 millionEPS Beat Rate2 of last 8 quartersPrepare for the Q3 2026 CallEarnings HistoryCompany ProfileQ2 2026 Earnings ReportQ1 2026 Earnings ReportQ4 2025 Earnings Report Sensus Healthcare Q3 2026 Earnings FAQ When does Sensus Healthcare report Q3 2026 earnings? Sensus Healthcare (NASDAQ:SRTS) is estimated to report Q3 2026 earnings on Thursday, November 5, 2026, before market opens. This date is estimated from past reporting schedules and may change once the company confirms it. What time is Sensus Healthcare's Q3 2026 earnings call? Sensus Healthcare's Q3 2026 earnings conference call is scheduled for Thursday, November 5, 2026 at 4:30 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for Sensus Healthcare? Analysts expect Sensus Healthcare to post earnings of -$0.0550 per share for Q3 2026. How much revenue is Sensus Healthcare expected to report? The consensus revenue estimate for Sensus Healthcare is $6.61 million for Q3 2026. Sensus Healthcare Earnings HeadlinesFinancial Comparison: Sensus Healthcare (NASDAQ:SRTS) versus Integer (NYSE:ITGR)October 5, 2026 | americanbankingnews.comSensus Healthcare IncAugust 31, 2026 | money.usnews.comMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up Amazon and Netflix under $3 per share in 2005. Now the chief investment strategist at The Oxford Club has identified three AI stocks he believes could be the most profitable investments of the next decade.October 13 at 1:00 AM | The Oxford Club (Ad)Sensus (SRTS) Q2 2026 Earnings Call TranscriptAugust 21, 2026 | finance.yahoo.comSensus outlines shift to $250,000 average selling price as it targets a stronger second halfAugust 14, 2026 | seekingalpha.comSensus Healthcare, Inc. (SRTS) Q2 2026 Earnings Call TranscriptAugust 13, 2026 | seekingalpha.comSee More Sensus Healthcare Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Sensus Healthcare? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Sensus Healthcare and other key companies, straight to your email. Email Address About Sensus HealthcareSensus Healthcare (NASDAQ:SRTS) (NASDAQ: SRTS) develops and markets non-invasive medical devices for dermatology and oncology. The company’s primary focus is superficial radiation therapy, a low-energy X-ray treatment designed to treat conditions affecting or located near the surface of the skin. Its product portfolio includes the SRT-100 system and related platforms, which are used primarily in the treatment of non-melanoma skin cancers such as basal cell carcinoma and squamous cell carcinoma, as well as keloid scars. Sensus also offers technologies intended to support treatment planning and delivery, including image-guided approaches designed to help clinicians target affected tissue. Founded in 2010 and headquartered in Boca Raton, Florida, Sensus Healthcare markets its systems to dermatology practices, radiation oncology providers, hospitals and other healthcare institutions. The company serves customers in the United States and selected international markets through direct sales and distribution relationships.View Sensus Healthcare ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles A Chinese Rival Just Spooked Memory Stocks—How Worried Should Micron Investors Be?Surgical Precision, Sustainable Returns: Johnson & Johnson Secures its Cash Flow RunwayJPMorgan Earnings Miss Estimates But Reveal Broad-Based StrengthAmazon's $220 Billion AI Bet Is Getting Bigger—Can Earnings Justify the Spending?A Silent Winner: Texas Instruments Anchors the AI SupercycleDelta's Guidance Cut Could Spell Trouble for the Airline Industry5 Retail Picks to Watch as the Holiday Shopping Season Nears Upcoming Earnings Bank of America (10/14/2026)BlackRock (10/14/2026)Morgan Stanley (10/14/2026)Progressive (10/14/2026)Fastenal (10/14/2026)ASML (10/14/2026)Interactive Brokers Group (10/15/2026)Marsh & McLennan Companies (10/15/2026)The PNC Financial Services Group (10/15/2026)Charles Schwab (10/15/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
